Buy This 1 Cannabis Stock for Longer-Term Growth Potential

Tilray (NASDAQ:TLRY) could be the right stock at the right time. But is it too expensive for casual investors right now?

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

There wasn’t much of a Santa Claus Rally. But considering the holiday period just past, perhaps that’s not much of a shock. The bullishness that characterized much of the latter half of the Year That Shall Not Be Named had largely leached out of the markets come December. There was still a fair amount of green ink in the markets at the end of the year. But this week has seen a lot of red ink taking its place.

Weighing price with growth potential

January is often a good time to pick up a bargain. 2021 is already proving that this year is no exception. A lot of quality names are on sale. For cannabis investors still hemming and hawing over the merger of Tilray (NASDAQ:TLRY) and Aphria (TSX:APHA)(NASDAQ:APHA), a potential pullback in share prices could offer a buying opportunity to scoop up some knocked-down stock.

Tilray investors have been keen on the news. The marijuana product developer’s stock jumped 22.8% as the potential acquisition made waves in the investment community. The gains fell away by the end of that week, though, to close up 1.2% just two days later. Aphria closed out that week up 2.6%. This month sees Tilray up 9.8%, and Aphria up 2.9%. But in the already volatile January market, a retreat could be imminent.

A future wide-moat cannabis stock?

Cannabis still has a long way to go before it’s a trusted asset. It’s certainly not the kind of commodity that can be packed with confidence into a lower risk portfolio. Consider, for example, a Tax-Free Savings Acount (TFSA) founded on such asset classes as chemicals and metals. What would it take for marijuana to be included on this list? For the general investor who is still dubious about cannabis growth potential, the challenges might always remain insurmountable.

But in years to come, such names as Tilray could come to command positions of wide-moat authority. This would take a period of high-level M&A. But that period has now been kick-started. Whether Tilray will be one of the eventual market leaders is of course up to history to decide. For now, though, Tilray could be a tentative buy for speculative investors going long on the green stuff.

Now, Tilray may be hot of late, but investors may want to treat this name with caution. Its 36-month beta is way up at 3.17. Consider, for a moment, the volatility of the market in the last three years. This stock is more than three times as frothy – and much of that froth has been churned up in the last 12 months alone. In just the last three months, Tilray has gained 70%.

In summary, Tilray is worth buying for a number of reasons. But because this is still a highly speculative market, Tilray may need to come down in price. Yes, there’s that 42% 12-month overall decline. But this stock still trades with a P/B ratio of 6.1. Considering that pot stocks can sell at their book price right now, Tilray may still be too rich for some investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »